Lusine Gazaryan
Lusine Gazaryan has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Andrey S. Anikeev
Peoples’ Friendship University of Russia
3 shared publications - Irina Mikhaylovna Ordiyants
Peoples’ Friendship University of Russia named after Patrice Lumumba, Moscow
3 shared publications - Nadezhda M. Startseva
RUDN University
3 shared publications - Asya Kuliyeva
Department of Pathological Anatomy, Medical Institute, Patrice Lumumba Peoples’ Friendship University of Russia, 117198 Moscow, Russia
2 shared publications - Evgeniya Neshcherova2 shared publications
- A.M. Savicheva1 shared publication
Latest Publications
- 28 February 2025
- Published by European Scientific Society in Archiv Euromedica
- Vol. 15 (1)
Metabolomic profiling of patients with gestational diabetes mellitus
Relevance. Pregnancy in women with carbohydrate metabolism disorders is classified as a high-risk group for early reproductive losses, obstetric complications, and perinatal morbidity, despite undeniable progress in understanding the pathogenesis, timely correction, and prevention of complications in this cohort of women. Aim: To study the metabolomic profile of amino acids in women with gestational diabetes mellitus (GDM) to identify potential biomarkers for predicting obstetric and perinatal complications. Materials and Methods: The study involved 50 pregnant women in the third trimester: 25 with GDM (GDM group) and 25 without GDM (control group). The concentration of 26 amino acids in a morning urine sample was determined for all participants, with analysis performed on the Agilent 1200 HPLC chromatographic system. Statistical processing of the data was carried out using IBM SPSS v. 26. Results: Three significant metabolites — valine, lysine, and glutamine — were identified. In GDM group, lysine levels were 5.3 times lower, valine 2 times lower, and glutamine 1.61 times lower compared to the control group. These changes may reflect GDM pathogenesis and predict complications. Conclusion: To enhance the effectiveness of diagnosis, individual management of pregnant women, and prevention of complications in women with GDM, it is important to consider the reduction in concentrations of key amino acids such as valine, lysine, and glutamine, which can serve as predictors of carbohydrate metabolism disorders.
- 28 February 2025
- Published by European Scientific Society in Archiv Euromedica
- Vol. 15 (1)
Metabolomic profiling of patients with gestational diabetes mellitus
Relevance. Pregnancy in women with carbohydrate metabolism disorders is classified as a high-risk group for early reproductive losses, obstetric complications, and perinatal morbidity, despite undeniable progress in understanding the pathogenesis, timely correction, and prevention of complications in this cohort of women. Aim: To study the metabolomic profile of amino acids in women with gestational diabetes mellitus (GDM) to identify potential biomarkers for predicting obstetric and perinatal complications. Materials and Methods: The study involved 50 pregnant women in the third trimester: 25 with GDM (GDM group) and 25 without GDM (control group). The concentration of 26 amino acids in a morning urine sample was determined for all participants, with analysis performed on the Agilent 1200 HPLC chromatographic system. Statistical processing of the data was carried out using IBM SPSS v. 26. Results: Three significant metabolites — valine, lysine, and glutamine — were identified. In GDM group, lysine levels were 5.3 times lower, valine 2 times lower, and glutamine 1.61 times lower compared to the control group. These changes may reflect GDM pathogenesis and predict complications. Conclusion: To enhance the effectiveness of diagnosis, individual management of pregnant women, and prevention of complications in women with GDM, it is important to consider the reduction in concentrations of key amino acids such as valine, lysine, and glutamine, which can serve as predictors of carbohydrate metabolism disorders.
- Open Access
- 26 September 2024
- Published by Kemerovo State Medical University in Fundamental and Clinical Medicine
- Vol. 9 (3) , 39-46
Micronutrient homeostasis disturbances in women with gestational diabetes mellitus and subclinical hypothyroidism: effects on pregnancy and outcomes
Aim. To characterize micronutrient homeostasis in women with a combination of gestational diabetes mellitus (GDM) and subclinical hypothyroidism (SCH), and to determine the significance of micronutrient imbalance in complicated pregnancies.Material and Methods. The study analyzed 439 birth histories of patients with GDM and SCH, who underwent plasma micronutrient analysis at 12−13 weeks of gestation. The study examined the patients' anthropometric and medical history data, complications during the current pregnancy, the timing and method of delivery, and newborn conditions. Some of these indicators were compared with previously obtained plasma micronutrient levels (Al, Co, Cu, Fe and others) measured at 12−13 weeks of gestation.Results. The analysis of micronutrient concentrations in plasma at 12−13 weeks of gestation revealed iron deficiency in 250 patients (57%), iodine deficiency in 231 patients (52.6%), cobalt deficiency in 229 patients (52.2%), vitamin B12 deficiency in 285 patients (64.9%), and vitamin D deficiency in 280 patients (63.6%). Iron deficiency was significantly more common in pregnant women with overweight and obesity than in those with normal body weight (χ2 =.14 and 5.32, respectively). The risk of developing iron deficiency also increased with higher body weight (1.81-fold for overweight (95% CI 1.2–2.73) and 2.07-fold for obesity (95% CI 1.11–3.86). Around 50% of patients with threatened preterm birth had cobalt deficiency and 59% of patients with anemia had iron deficiency. Selenium, calcium, and vitamin B12 deficiencies were observed in 55%, 70%, and 73% of patients with preeclampsia (PE), respectively.Conclusion. The observed deficiency of certain micronutrients in specific pregnancy complications suggests that correcting micronutrient levels during pre-conception or early gestation may improve pregnancy outcomes.
- 26 September 2024
- Published by Kemerovo State Medical University in Fundamental and Clinical Medicine
- Vol. 9 (3) , 39-46
Open AccessMicronutrient homeostasis disturbances in women with gestational diabetes mellitus and subclinical hypothyroidism: effects on pregnancy and outcomes
Aim. To characterize micronutrient homeostasis in women with a combination of gestational diabetes mellitus (GDM) and subclinical hypothyroidism (SCH), and to determine the significance of micronutrient imbalance in complicated pregnancies.Material and Methods. The study analyzed 439 birth histories of patients with GDM and SCH, who underwent plasma micronutrient analysis at 12−13 weeks of gestation. The study examined the patients' anthropometric and medical history data, complications during the current pregnancy, the timing and method of delivery, and newborn conditions. Some of these indicators were compared with previously obtained plasma micronutrient levels (Al, Co, Cu, Fe and others) measured at 12−13 weeks of gestation.Results. The analysis of micronutrient concentrations in plasma at 12−13 weeks of gestation revealed iron deficiency in 250 patients (57%), iodine deficiency in 231 patients (52.6%), cobalt deficiency in 229 patients (52.2%), vitamin B12 deficiency in 285 patients (64.9%), and vitamin D deficiency in 280 patients (63.6%). Iron deficiency was significantly more common in pregnant women with overweight and obesity than in those with normal body weight (χ2 =.14 and 5.32, respectively). The risk of developing iron deficiency also increased with higher body weight (1.81-fold for overweight (95% CI 1.2–2.73) and 2.07-fold for obesity (95% CI 1.11–3.86). Around 50% of patients with threatened preterm birth had cobalt deficiency and 59% of patients with anemia had iron deficiency. Selenium, calcium, and vitamin B12 deficiencies were observed in 55%, 70%, and 73% of patients with preeclampsia (PE), respectively.Conclusion. The observed deficiency of certain micronutrients in specific pregnancy complications suggests that correcting micronutrient levels during pre-conception or early gestation may improve pregnancy outcomes.
- Open Access
- 1 January 2024
- Published by Geotar-Media Publishing Group in Obstetrics and gynecology: News, Opinions, Training
- Vol. 12 (s)
Criteria of metabolic disorders in the prediction of gestational diabetes mellitus: analytical review
Критерии нарушения метаболома в прогнозировании гестационного сахарного диабета: аналитический обзор
- 1 January 2024
- Published by Geotar-Media Publishing Group in Obstetrics and gynecology: News, Opinions, Training
- Vol. 12 (s)
Open AccessCriteria of metabolic disorders in the prediction of gestational diabetes mellitus: analytical review
Критерии нарушения метаболома в прогнозировании гестационного сахарного диабета: аналитический обзор
- Open Access
- 1 January 2023
- Published by NP Rusmedical Group in Doctor.Ru
- Vol. 22 (1)
Features of Metabolism in Women with Preeclampsia Combined with Gestational Diabetes Mellitus
Objective of the Review: To summarize the proven prognostic and diagnostic criteria for gestational complications caused by a combination of gestational diabetes mellitus (GDM) and preeclampsia (PE). Key points. There is an analytical review of the modern paradigm of GDM and PE, their complications, as well as perinatal and long-term outcomes for mother and child. The data on clinical, anamnestic and laboratory risk factors of PE in GDM are systematized. A close relationship between the mechanisms of PE and GDM development — angiogenic imbalance and metabolic disorders in the placenta is described. Conclusion. GDM is recognized as an independent risk factor for the development of PE, and this risk is the greater the less GDM is compensated. Polycystic ovary syndrome and an increased body mass index as concomitant factors of metabolic disorders also increase the risk of developing PE. The supposed pathogenetic commonality of GDM and PE is the presence of oxidative stress and metaflammation, which increase insulin resistance and cause endothelial dysfunction. Keywords: preeclampsia, gestational diabetes mellitus, metabolism, risk factors, pathogenetic commonality.
- 1 January 2023
- Published by NP Rusmedical Group in Doctor.Ru
- Vol. 22 (1)
Open AccessFeatures of Metabolism in Women with Preeclampsia Combined with Gestational Diabetes Mellitus
Objective of the Review: To summarize the proven prognostic and diagnostic criteria for gestational complications caused by a combination of gestational diabetes mellitus (GDM) and preeclampsia (PE). Key points. There is an analytical review of the modern paradigm of GDM and PE, their complications, as well as perinatal and long-term outcomes for mother and child. The data on clinical, anamnestic and laboratory risk factors of PE in GDM are systematized. A close relationship between the mechanisms of PE and GDM development — angiogenic imbalance and metabolic disorders in the placenta is described. Conclusion. GDM is recognized as an independent risk factor for the development of PE, and this risk is the greater the less GDM is compensated. Polycystic ovary syndrome and an increased body mass index as concomitant factors of metabolic disorders also increase the risk of developing PE. The supposed pathogenetic commonality of GDM and PE is the presence of oxidative stress and metaflammation, which increase insulin resistance and cause endothelial dysfunction. Keywords: preeclampsia, gestational diabetes mellitus, metabolism, risk factors, pathogenetic commonality.